Alan’s battle with stage 4 metastatic melanoma began in June 2017, marked by multiple brain and lung tumors. Following surgeries and radiation, he underwent immunotherapy in July 2017. He’s now cancer free and excited to share why you should participate in #Immune2Cancer Day.
Alan’s #Immune2Cancer Message
Stay up to date
Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.
